{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:36:00Z","timestamp":1774114560184,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.rmed.2003.09.015","type":"journal-article","created":{"date-parts":[[2003,11,8]],"date-time":"2003-11-08T07:16:02Z","timestamp":1068275762000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1"],"prefix":"10.1016","volume":"98","author":[{"given":"Noriho","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kakugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ichi","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2003.09.015_BIB1","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rmed.2003.09.015_BIB2","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rmed.2003.09.015_BIB3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2003.09.015_BIB4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2003.09.015_BIB5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0140-6736(92)90699-4","article-title":"HTLV-I and uveitis","volume":"339","author":"Mochizuki","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2003.09.015_BIB6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(89)90038-X","article-title":"Chronic inflammatory arthropathy associated with HTLV-I","volume":"1","author":"Nishioka","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2003.09.015_BIB7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1183\/09031936.93.06070938","article-title":"Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis","volume":"6","author":"Sugimoto","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2003.09.015_BIB8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","article-title":"T-lymphocyte alveolitis in HTLV-I-associated myelopathy","volume":"2","author":"Sugimoto","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2003.09.015_BIB9","first-page":"775","article-title":"Bronchopneumonopathy in HTLV-1 associated myelopathy (HAM) and non-HAM HTLV-1 carriers","volume":"30","author":"Maruyama","year":"1992","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.rmed.2003.09.015_BIB10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.rmed.2003.09.015_BIB11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.148.4.1274","article-title":"The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen","volume":"148","author":"Watanabe-Fukunaga","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family","volume":"75","author":"Suda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.rmed.2003.09.015_BIB14","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.154.8.3806","article-title":"Expression of the Fas ligand in cells of T cell lineage","volume":"154","author":"Suda","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/j.1460-2075.1995.tb07096.x","article-title":"Expression of the functional soluble form of human fas ligand in activated lymphocytes","volume":"14","author":"Tanaka","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.rmed.2003.09.015_BIB16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.191.7.1209","article-title":"Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival","volume":"191","author":"Hohlbaum","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB18","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.157.9.3918","article-title":"Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand","volume":"157","author":"Suda","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB19","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1002\/1097-0142(20001215)89:12<2560::AID-CNCR7>3.0.CO;2-Q","article-title":"Circulating soluble Fas ligand in patients with gastric carcinoma","volume":"89","author":"Tsutsumi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.rmed.2003.09.015_BIB20","first-page":"3529","article-title":"Circulating soluble Fas concentration in breast cancer patients","volume":"5","author":"Ueno","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rmed.2003.09.015_BIB21","first-page":"1282","article-title":"Increased soluble CD95 (sFas\/CD95) serum level correlates with poor prognosis in melanoma patients","volume":"7","author":"Ugurel","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rmed.2003.09.015_BIB22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/107999099313208","article-title":"Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy","volume":"19","author":"Sakai","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.rmed.2003.09.015_BIB23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2169\/internalmedicine.36.166","article-title":"Serum levels of soluble Fas\/APO-1 receptor in human retroviral infection and associated diseases","volume":"36","author":"Kamihira","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-5728(99)00095-8","article-title":"Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy\/tropical spastic paraparesis patients","volume":"98","author":"Saito","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1348-0421.1994.tb01744.x","article-title":"Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM\/TSP patients and HTLV-I carriers","volume":"38","author":"Mukae","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/ajrccm.160.3.9808125","article-title":"Induction of lymphocytic inflammatory changes in lung interstitium by human T lymphotropic virus type I","volume":"160","author":"Kawakami","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2249.1994.tb06541.x","article-title":"Expression of human T lymphotropic virus type 1 (HTLV-1) tax\/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals","volume":"96","author":"Higashiyama","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB28","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.169.5.1853","article-title":"Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related","volume":"169","author":"Noma","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jcb.240460405","article-title":"Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia","volume":"46","author":"Tendler","year":"1991","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.rmed.2003.09.015_BIB30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0925-5710(97)00077-7","article-title":"HTLV-1-associated diseases","volume":"66","author":"Watanabe","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB31","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1099\/0022-1317-78-12-3277","article-title":"Role of the Fas\/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator","volume":"78","author":"Chen","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/aid.1998.14.261","article-title":"Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy\/tropical spastic paraparesis patients","volume":"14","author":"Arai","year":"1998","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.rmed.2003.09.015_BIB33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1089\/aid.1994.10.1259","article-title":"Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax","volume":"10","author":"Copeland","year":"1994","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.rmed.2003.09.015_BIB34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.186.1.7","article-title":"Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells","volume":"186","author":"Xu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmed.2003.09.015_BIB35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1378\/chest.119.1.196","article-title":"BAL and serum IgG levels in healthy asymptomatic HIV-infected patients","volume":"119","author":"Fahy","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2003.09.015_BIB36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10428190109057967","article-title":"Soluble Fas (APO-1\/CD95) isoform in adult T-cell leukemia","volume":"41","author":"Kamihira","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.rmed.2003.09.015_BIB37","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1073\/pnas.85.24.9733","article-title":"Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth","volume":"85","author":"Wano","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rmed.2003.09.015_BIB38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","volume":"2","author":"O\u2019Shea","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1165\/ajrcmb.20.1.2941","article-title":"The involvement of Fas\u2013Fas ligand pathway in fibrosing lung diseases","volume":"20","author":"Kuwano","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmed.2003.09.015_BIB40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1378\/chest.118.2.451","article-title":"Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia","volume":"118","author":"Kuwano","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2003.09.015_BIB41","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0264-410X(99)00492-2","article-title":"Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans","volume":"18","author":"Gupta","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.rmed.2003.09.015_BIB42","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/clinchem\/42.12.1911","article-title":"Highly sensitive ELISA for soluble Fas in serum","volume":"42","author":"Seishima","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.rmed.2003.09.015_BIB43","first-page":"311","article-title":"Plasma soluble Fas ligand concentration","volume":"8","author":"Ichikura","year":"2001","journal-title":"Oncol Rep"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611103003561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611103003561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:05:51Z","timestamp":1760609151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611103003561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0954611103003561"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2003.09.015","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2003.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}